Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
NaturalAntibody logo — Accelerating antibody discovery with AI bioinformatics solut...

NaturalAntibody

Accelerating antibody discovery with AI bioinformatics solutions for the pharma industry

Founded 2020 Poland Poland 21 employees Grant Total: $6.48M Biotechnology, Clean Energy

General Information

Company Name NaturalAntibody
Founded Year 2020
Location Poland Poland
Employees 21
Industries Biotechnology, Clean Energy
Funding Stage Grant
Social

Get notified when NaturalAntibody moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About NaturalAntibody

NaturalAntibody is a biotechnology startup founded in 2020 and headquartered in Poland. The company's slogan, "Accelerating antibody discovery with AI bioinformatics solutions for the pharma industry," encapsulates its core mission. NaturalAntibody specializes in developing bioinformatics solutions to streamline the engineering of antibody-based therapeutics. By gathering, integrating, and repurposing antibody data from both public and proprietary repositories, the company leverages AI to gain insights into antibody structure, function, and diversity. This, in turn, aids researchers in expediting the design of therapeutic antibodies and enhances the safety of the drug discovery process. In June 15, 2023, NaturalAntibody secured a $100.00K grant investment to further bolster its innovative solutions. Although the details of the investor(s) behind this particular investment round are not provided, this funding is poised to fuel the startup's ongoing efforts in revolutionizing antibody discovery through AI-powered bioinformatics. With its focus on biotechnology and clean energy, NaturalAntibody stands at the forefront of leveraging advanced technology to drive impactful developments within the pharmaceutical industry.

Taxonomy: Bioinformatics, Antibody discovery, Therapeutic antibodies, Drug discovery, AI solutions, Data integration, Pharmaceutical industry

Services & Products

Data-driven antibody discovery and optimization
Structural modeling and prediction
Immunogenicity and liability assessment
Machine learning and predictive analytics for antibody design and development

Target Customers

Biotech and pharmaceutical companies Research institutions Drug development professionals Bioinformatics and computational biology experts

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• - 15 Jun 2023
Seed Round •••••• - 08 Jan 2023
Grant •••••• - 10 Oct 2022
Grant •••••• - 21 Dec 2021
Pre Seed Round •••••• 1
Investor
24 Aug 2021

NaturalAntibody Alternatives & Competitors

NaturalAntibody vs
Dima Biotechnology
Dima Biotechnology United States

Recombinant monoclonal antibodies and membrane proteins for drug discovery.

Angel
6 employees
Biotechnology, Health Care
NaturalAntibody vs
Capralogics Inc
Capralogics Inc

Your Leading Provider of Polyclonal Antibodies and Specialized Camelid Antibody Development!

12 employees
Biotechnology, Industrial
NaturalAntibody vs
Synbio Technologies
Synbio Technologies United States

Changing the world, one sequence at a time.

25 employees
Biotechnology, Health Care
Also compare with: NaturalAntibody vs Ablexis, LLC Ablexis, LLC

FAQ About NaturalAntibody

Accelerating antibody discovery with AI bioinformatics solutions for the pharma industry
NaturalAntibody was founded in 2020.
NaturalAntibody is headquartered in Poland.
NaturalAntibody operates in the following industries: Biotechnology, Clean Energy.
NaturalAntibody has approximately 21 employees.
NaturalAntibody has completed 5 funding rounds, raising a total of $6.48M. The latest funding stage is Grant.
NaturalAntibody offers: Data-driven antibody discovery and optimization, Structural modeling and prediction, Immunogenicity and liability assessment, Machine learning and predictive analytics for antibody design and development.
Top alternatives and competitors to NaturalAntibody include Dima Biotechnology, Capralogics Inc, Synbio Technologies, AbTherx, Yumab GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NaturalAntibody and Dima Biotechnology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors NaturalAntibody and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy